Petra Langerbeins

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

Kirsten Fischer, Jasmin Bahlo, Anna Maria Fink et al. · Blood · 2015 · 700 citations · Full text

Life Sciences, Immunology, Oncology +8

Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group

Gábor Kovács, Sandra Robrecht, Anna Maria Fink et al. · Journal of Clinical Oncology · 2016 · 174 citations

Medicine, Hematology, Oncology +16

COVID-19 in patients with hematologic malignancy

Petra Langerbeins, Michael Hallek · Blood · 2022 · 140 citations · Full text

Medicine, Hematology, Oncology +12

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Adalgisa Condoluci, Lodovico Terzi di Bergamo, Petra Langerbeins et al. · Blood · 2020 · 139 citations · Full text

Medicine, Hematology, Oncology +13

Poor efficacy and tolerability of <scp>R‐CHOP</scp> in relapsed/refractory chronic lymphocytic leukemia and <scp>R</scp>ichter transformation

Petra Langerbeins, Raymonde Busch, Nadine Anheier et al. · American Journal of Hematology · 2014 · 112 citations · Full text

Medicine, Hematology, Oncology +17